# Replimune Group, Inc.: Form 8-K, filed Sep 4, 2025

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2025-09-04
- Accepted by EDGAR: Sep 4, 2025, 16:05 ET
- Period: 2025-09-02
- Accession: 0001104659-25-087464
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465925087464/tm2525185d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465925087464/

## Items reported

- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465925087464/tm2525185d1_8k.htm

Filed Sep 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-087464. Last ingested by Listed: Nov 2, 2026, 16:50 ET. No prices; not investment advice.